β-PIX is critical for transplanted mesenchymal stromal cell migration

Seong Ho Koh, Yong Min Huh, Min Young Noh, Hyun Young Kim, Kyung Suk Kim, Eun Sook Lee, Hyun Ju Ko, Goang Won Cho, A. Rum Yoo, Ho Taek Song, Sejin Hwang, Kwangyeol Lee, Seungjoo Haam, Joseph A. Frank, Jin Suck Suh, Seung Hyun Kim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Bone marrow-derived mesenchymal stromal cells (MSCs) have been used successfully as a source of stem cells for treating neurodegenerative diseases. However, for reasons that are not clear, autologous MSC transplants have not yielded successful results in human trials. To test one possible reason, we compared the migratory ability of MSCs from amyotrophic lateral sclerosis (ALS) patients with those of healthy controls. We found that MSCs derived from ALS patients (ALS-MSCs) had a reduced ability to migrate, which may explain why autologous transplantation is not successful. We also found that expression of one of the intracellular factors implicated in migration, β-PIX, was significantly reduced in ALS-MSCs compared with healthy stem cells. Restoration of β-PIX expression by genetic manipulation restored the migratory ability of ALS-MSCs, and inhibition of β-PIX expression with shRNA reduced the migration of healthy MSCs. We suggest that transplantation of allogeneic or genetically modified autologous stem cells might be a more promising strategy for ALS patients than transplantation of autologous stem cells.

Original languageEnglish
Pages (from-to)1989-1999
Number of pages11
JournalStem Cells and Development
Volume21
Issue number11
DOIs
Publication statusPublished - 2012 Jul 20

Fingerprint

Stem cells
Mesenchymal Stromal Cells
Cell Movement
Amyotrophic Lateral Sclerosis
Neurodegenerative diseases
Transplants
Stem Cells
Small Interfering RNA
Restoration
Bone
Cells
Autologous Transplantation
Homologous Transplantation
Stem Cell Transplantation
Neurodegenerative Diseases
Bone Marrow

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Hematology

Cite this

Koh, S. H., Huh, Y. M., Noh, M. Y., Kim, H. Y., Kim, K. S., Lee, E. S., ... Kim, S. H. (2012). β-PIX is critical for transplanted mesenchymal stromal cell migration. Stem Cells and Development, 21(11), 1989-1999. https://doi.org/10.1089/scd.2011.0430

β-PIX is critical for transplanted mesenchymal stromal cell migration. / Koh, Seong Ho; Huh, Yong Min; Noh, Min Young; Kim, Hyun Young; Kim, Kyung Suk; Lee, Eun Sook; Ko, Hyun Ju; Cho, Goang Won; Yoo, A. Rum; Song, Ho Taek; Hwang, Sejin; Lee, Kwangyeol; Haam, Seungjoo; Frank, Joseph A.; Suh, Jin Suck; Kim, Seung Hyun.

In: Stem Cells and Development, Vol. 21, No. 11, 20.07.2012, p. 1989-1999.

Research output: Contribution to journalArticle

Koh, SH, Huh, YM, Noh, MY, Kim, HY, Kim, KS, Lee, ES, Ko, HJ, Cho, GW, Yoo, AR, Song, HT, Hwang, S, Lee, K, Haam, S, Frank, JA, Suh, JS & Kim, SH 2012, 'β-PIX is critical for transplanted mesenchymal stromal cell migration', Stem Cells and Development, vol. 21, no. 11, pp. 1989-1999. https://doi.org/10.1089/scd.2011.0430
Koh, Seong Ho ; Huh, Yong Min ; Noh, Min Young ; Kim, Hyun Young ; Kim, Kyung Suk ; Lee, Eun Sook ; Ko, Hyun Ju ; Cho, Goang Won ; Yoo, A. Rum ; Song, Ho Taek ; Hwang, Sejin ; Lee, Kwangyeol ; Haam, Seungjoo ; Frank, Joseph A. ; Suh, Jin Suck ; Kim, Seung Hyun. / β-PIX is critical for transplanted mesenchymal stromal cell migration. In: Stem Cells and Development. 2012 ; Vol. 21, No. 11. pp. 1989-1999.
@article{70174b9d39664b91a59a403e03b7a912,
title = "β-PIX is critical for transplanted mesenchymal stromal cell migration",
abstract = "Bone marrow-derived mesenchymal stromal cells (MSCs) have been used successfully as a source of stem cells for treating neurodegenerative diseases. However, for reasons that are not clear, autologous MSC transplants have not yielded successful results in human trials. To test one possible reason, we compared the migratory ability of MSCs from amyotrophic lateral sclerosis (ALS) patients with those of healthy controls. We found that MSCs derived from ALS patients (ALS-MSCs) had a reduced ability to migrate, which may explain why autologous transplantation is not successful. We also found that expression of one of the intracellular factors implicated in migration, β-PIX, was significantly reduced in ALS-MSCs compared with healthy stem cells. Restoration of β-PIX expression by genetic manipulation restored the migratory ability of ALS-MSCs, and inhibition of β-PIX expression with shRNA reduced the migration of healthy MSCs. We suggest that transplantation of allogeneic or genetically modified autologous stem cells might be a more promising strategy for ALS patients than transplantation of autologous stem cells.",
author = "Koh, {Seong Ho} and Huh, {Yong Min} and Noh, {Min Young} and Kim, {Hyun Young} and Kim, {Kyung Suk} and Lee, {Eun Sook} and Ko, {Hyun Ju} and Cho, {Goang Won} and Yoo, {A. Rum} and Song, {Ho Taek} and Sejin Hwang and Kwangyeol Lee and Seungjoo Haam and Frank, {Joseph A.} and Suh, {Jin Suck} and Kim, {Seung Hyun}",
year = "2012",
month = "7",
day = "20",
doi = "10.1089/scd.2011.0430",
language = "English",
volume = "21",
pages = "1989--1999",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "11",

}

TY - JOUR

T1 - β-PIX is critical for transplanted mesenchymal stromal cell migration

AU - Koh, Seong Ho

AU - Huh, Yong Min

AU - Noh, Min Young

AU - Kim, Hyun Young

AU - Kim, Kyung Suk

AU - Lee, Eun Sook

AU - Ko, Hyun Ju

AU - Cho, Goang Won

AU - Yoo, A. Rum

AU - Song, Ho Taek

AU - Hwang, Sejin

AU - Lee, Kwangyeol

AU - Haam, Seungjoo

AU - Frank, Joseph A.

AU - Suh, Jin Suck

AU - Kim, Seung Hyun

PY - 2012/7/20

Y1 - 2012/7/20

N2 - Bone marrow-derived mesenchymal stromal cells (MSCs) have been used successfully as a source of stem cells for treating neurodegenerative diseases. However, for reasons that are not clear, autologous MSC transplants have not yielded successful results in human trials. To test one possible reason, we compared the migratory ability of MSCs from amyotrophic lateral sclerosis (ALS) patients with those of healthy controls. We found that MSCs derived from ALS patients (ALS-MSCs) had a reduced ability to migrate, which may explain why autologous transplantation is not successful. We also found that expression of one of the intracellular factors implicated in migration, β-PIX, was significantly reduced in ALS-MSCs compared with healthy stem cells. Restoration of β-PIX expression by genetic manipulation restored the migratory ability of ALS-MSCs, and inhibition of β-PIX expression with shRNA reduced the migration of healthy MSCs. We suggest that transplantation of allogeneic or genetically modified autologous stem cells might be a more promising strategy for ALS patients than transplantation of autologous stem cells.

AB - Bone marrow-derived mesenchymal stromal cells (MSCs) have been used successfully as a source of stem cells for treating neurodegenerative diseases. However, for reasons that are not clear, autologous MSC transplants have not yielded successful results in human trials. To test one possible reason, we compared the migratory ability of MSCs from amyotrophic lateral sclerosis (ALS) patients with those of healthy controls. We found that MSCs derived from ALS patients (ALS-MSCs) had a reduced ability to migrate, which may explain why autologous transplantation is not successful. We also found that expression of one of the intracellular factors implicated in migration, β-PIX, was significantly reduced in ALS-MSCs compared with healthy stem cells. Restoration of β-PIX expression by genetic manipulation restored the migratory ability of ALS-MSCs, and inhibition of β-PIX expression with shRNA reduced the migration of healthy MSCs. We suggest that transplantation of allogeneic or genetically modified autologous stem cells might be a more promising strategy for ALS patients than transplantation of autologous stem cells.

UR - http://www.scopus.com/inward/record.url?scp=84863945127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863945127&partnerID=8YFLogxK

U2 - 10.1089/scd.2011.0430

DO - 10.1089/scd.2011.0430

M3 - Article

VL - 21

SP - 1989

EP - 1999

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 11

ER -